Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Cash Flows

v3.5.0.2
Consolidated Statements of Cash Flows - USD ($)
 9 Months Ended
Jun. 30, 2016
Jun. 30, 2015
Cash flows from operating activities:    
Net loss $ (4,175,491) $ (1,227,206)
Adjustments to reconcile net loss to cash used in operating activities:    
Stock-based compensation 769,671 859,627
Noncash interest expense on notes payable 243,674 212,332
Issuance of restricted stock for services 52,500 8,625
Gain on exercise of warrants and conversion of debt (142,964) (299,321)
Loss on warrant derivative modification 0 996,813
Decrease to fair value of derivative (192,128) (3,546,924)
(Increase) decrease in:    
Prepaid expenses and other current assets (115,070) (621)
Increase (decrease) in:    
Accounts payable 21,301 323,850
Accrued expenses and other liabilities (123,113) 46,059
Net cash used in operating activities (3,661,620) (2,626,766)
Cash flows from financing activities:    
Proceeds from exercise of warrants 2,057,648 1,251,000
Net proceeds from issuance of common stock and warrants 3,388,919 3,066,000
Proceeds from issuance of convertible notes 0 750,000
Net cash provided by financing activities 5,446,567 5,067,000
Net increase in cash 1,784,947 2,440,234
Cash, beginning of period 3,960,100 833,520
Cash, end of period 5,745,047 3,273,754
Non-cash financing activities    
Financing Costs on Issuance Of Common Stock And Warrants 333,320 150,000
Conversion of 8% convertible notes and accrued interest to common stock 644,900 0
Issuance of inducement shares 0 100,050
Reclass of Series A and Series C Warrants from derivative liabilities to equity $ 0 $ 3,263,753